09.10.24 -- How To Minimize The Impact Of Stability Testing On Gene Therapy Batch Yield

One of the most intriguing, high-stakes aspects of R&D is the realm of biosimilars. Explore the challenges of biosimilar production as well as aseptic processing considerations for biosimilars.

Are you up to the task of bringing a biologic drug to market? Do you have a strategy and plan for moving forward? Here, we explore this from a biopharma process development and manufacturing perspective.

This presentation explores natural killer (NK) cells and how conditions for electroporating primary NK cells can be optimized to improve cell viability, transfection efficiency, and other factors.

Watch to learn about a new serum-free T cell media designed to overcome the barriers hindering CAR-T therapies and explore the importance of transduction efficiency in CAR T-cell therapy.

Unprecedented efficacy in targeting cancer has been demonstrated with CAR T-cell therapy. Discover a device that allows the generation of CAR T-cells in a single automated and closed system.

Explore a portfolio of necessary controls for assessing cell health that can increase accuracy through the removal of dead cells.

Get an overview of how mass photometry works and the effort being put in to establish an analytical workflow for gene therapy products.

Enhance the quality and safety of your BsAb therapeutics with a highly efficient with the right chromatography hydroxyapatite media.

Are you searching for a better way to calculate growth rate? Consider a new approach that performs the rate calculations using a simple method to correct for volume changes.

Better understand the differences between large- and small-volume parenteral injectable drugs, their comparative sizes, types, sterilization processes, and applications.